We’ve raised $11M in seed funding led by Threshold Ventures, with participation from Informed Ventures, Alpaca VC, VitalStage Ventures, Correlation Ventures, DarkMode Ventures, Mike Mahlkow, Cross Atlantic Angels, Max Keller, JD Montgomery, Adam Grosser, and others, to continue to build AI capable of autonomous scientific discovery.
Over the last year, we launched Aristotle, now used by thousands of researchers across some of the most demanding institutions in science, including Pfizer, the FDA, Harvard, GSK, Merck, MIT, AstraZeneca, Stanford, Johnson & Johnson, the NIH, Bristol-Myers Squibb, the European Medicines Agency, Oxford, Yale, and Johns Hopkins.
We also built Columbus-1, our autonomous research system for long-horizon scientific reasoning. It has already produced novel results across a growing set of scientific and engineering domains. Read the announcement, or the full technical paper on arXiv.
This funding will help us grow the team, expand our research, and push the work further than most people expect is possible right now.
If you want to do your life’s work with us, please apply here.
Autopoiesis: From Greek “auto” (self) + “poiesis” (creation).